Ivan Sabol

Dr. Ivan Sabol

Molecular medicine, Rudjer Boskovic Institute, Zagreb, Zagreb, Grad, Croatia
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
KSKristina Starcevic
Kristina Starcevic
MKMarijeta Kralj
Marijeta Kralj
KEKatja Ester
Katja Ester
Ivan SabolIvan Sabol
Ivan Sabol
MGMagdalena Grce
Magdalena Grce
GKGrace Karminski-Zamola
Grace Karminski-Zamola

6 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Ena PešutEna Pešut
Ena Pešut
AĐAnamaria Đukić
Anamaria Đukić
Lucija Lulic HorvatLucija Lulic Horvat
Lucija Lulic Horvat
JSJosipa Skelin
Josipa Skelin
IŠIvana Šimić
Ivana Šimić
MGMagdalena Grce
Magdalena Grce
Human papillomaviruses (HPVs), which are small, double-stranded, circular DNA viruses infecting human epithelial cells, are associated with various benign and malignant lesions of mucosa and skin. Intensive research on the oncogenic potential of HPVs started in the 1970s and spread across Europe, including Croatia, and worldwide. Nowadays, the causative role of a subset of oncogenic or high-risk (HR) HPV types, led by HPV-16 and HPV-18, of different anogenital and head and neck cancers is well accepted. Two major viral oncoproteins, E6 and E7, are directly involved in the development of HPV-related malignancies by targeting synergistically various cellular pathways involved in the regulation of cell cycle control, apoptosis, and cell polarity control networks as well as host immune response. This review is aimed at describing the key elements in HPV-related carcinogenesis and the advances in cancer prevention with reference to past and on-going research in Croatia.

1 January 2021 in Medical Archives
Verified
Journal Article
Open access
IKIva Krolo
Iva Krolo
MBMatija Blazeka
Matija Blazeka
IMIvan Merdzo
Ivan Merdzo
IVIzabela Vrtar
Izabela Vrtar
Ivan SabolIvan Sabol
Ivan Sabol
IVIvanka Vickovic
Ivanka Vickovic
In the year 2020 we observe the world adapting to „new normal“ due to the COVID-19 pandemic, ways of which include physical distancing, hand hygiene, and wearing a face mask. There is no conclusive evidence about ocular manifestations of the new coronavirus infection, but cases of conjunctivitis, keratitis, and episcleritis have been reported in infected individuals. Determining if wearing a face mask during COVID-19 pandemic causes a new onset or deterioration of previously existing dry eye disease (DED). A prospective cohort study included 203 participants, all using surgical facemasks daily due to new regulations during COVID-19 pandemic. Participants completed a survey, containing modified Ocular Surface Disease Index (OSDI) questionnaire. They were divided into groups according to: sex, age, duration of face mask-wear, and existence of prior DED history. Our results indicate that women have a statistically higher OSDI score compared to men (14.4 (IQR = 2.4 – 41.7) vs. 5.0 (IQR = 0.0 – 24.4); P = .004). Age did not significantly affect OSDI median values. Group that used masks from 3 to 6 hours/day demonstrated significantly higher OSDI scores compared to <3 hour/day group (15.3 (IQR = 8.3 – 47.7) vs. 8.3 (IQR = 0.0 – 35.1); P = .001). OSDI score was significantly greater in participants with prior DED history compared to those without it (36.1 (IQR = 14.1 – 61.6) vs. 4.2 (IQR = 2.3 – 8.3); P <.001). Participants with prior DED exhibited greater worsening of their disturbances during mask wearing period compared to the ones without previous DED (54.8% vs. 17.7%, Chi-Square 28.3 DF1; P <.001), regardless of daily mask wear duration. Our study confirmed the existence of mask-associated dry eye (MADE), most profoundly in females, subjects with a history of prior DED, and if wearing a face mask lasts longer than 3 hours per day. Ophthalmologists should advise their patients of the potential ocular surface health risks related to inadequately fitted facemasks.

15 December 2015 in Acta Stomatologica Croatica
Verified
Journal Article
Open access
NPNikolina Petrušić
Nikolina Petrušić
MPMartina Posavec
Martina Posavec
Ivan SabolIvan Sabol
Ivan Sabol
Marinka Mravak-StipetićMarinka Mravak-Stipetić
Marinka Mravak-Stipetić
The purpose of this study was to examine the detrimental effect of smoking on the function of the salivary glands. The study was conducted on 60 patients who were divided into two groups: a test group which included smokers and control group represented by non-smokers. Each group included 30 patients. General information was collected from all the respondents via a questionnaire as well as the data on the duration of smoking and number of cigarettes smoked per day. Saliva was collected by spitting method in a graduated tube and the amount of unstimulated and stimulated saliva was measured and recorded in ml per minute. Stimulated saliva was collected immediately after rinsing the mouth with a 2% aqueous solution of citric acid which is carried salivary stimulation. The presence of pigmentation on the teeth and coated tongue were recorded during clinical examination. The degree of oral hygiene was determined by plaque index. All the obtained data were statistically analyzed with significance level p <0.05. The results showed no significant differences in the amount of saliva between smokers and non-smokers, however, the amount of saliva decreases significantly with the duration of smoking and increasing age of smokers. Also proven was the difference in the quality of saliva: smokers have thick saliva and nonsmokers predominantly serous. In addition, smokers have poorer oral hygiene status than non-smokers, and demonstrated a positive correlation between the level of oral hygiene and length of smoking tobacco. This study has proven that smoking adversely affects salivation: long-term smoking reduces the secretion of saliva and changes its quality.

1 June 2013 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
Mateja Janković MakekMateja Janković Makek
Mateja Janković Makek
MSM. Samarzija
M. Samarzija
Ivan SabolIvan Sabol
Ivan Sabol
MJM. Jakopovic
M. Jakopovic
VJV. Katalinic Jankovic
V. Katalinic Jankovic
JIJ. van Ingen
J. van Ingen
SETTING: The clinical relevance of non-tuberculous mycobacteria (NTM) in Croatia is unknown. OBJECTIVE: To estimate the isolation rate of NTM, record geographical differences and assess the burden of pulmonary NTM disease in Croatia. DESIGN: Nationwide retrospective cohort study of all Croatian residents with NTM isolated by culture in the period from 2006 to 2010. Microbiological criteria of the American Thoracic Society were used to establish a laboratory-based case definition of possible and probable NTM disease. RESULTS: Of 1187 individuals with pulmonary NTM isolates, 8.6% met the possible and 5.5% met the probable disease criteria. We estimated an annual incidence of probable pulmonary NTM disease of 0.23 per 100 000 population. This estimated annual incidence was 0.35/100 000 in the coastal region and 0.17/100 000 in the continental region. Species distribution differed between coastal and continental Croatia. NTM isolation frequency increased over the study period. CONCLUSION: Geography plays an important role in NTM species distribution and possible disease. The overall burden of NTM pulmonary disease in Croatia is still low compared to that of tuberculosis, but it is higher in the coastal region compared to the continental region.

3 August 2015 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
ZVZuzana Vojtechova
Zuzana Vojtechova
Ivan SabolIvan Sabol
Ivan Sabol
MSMartina Saláková
Martina Saláková
LTLubomir Turek
Lubomir Turek
MGMarek Grega
Marek Grega
RTRuth Tachezy
Ruth Tachezy
Integration, which leads to the disruption of the circular HPV genome, is considered as a critical, albeit not obligatory, step in carcinogenic progression. Although cervical carcinomas with extrachromosomal HPV plasmid genomes have been described, the virus is integrated in 70% of HPV16‐positive cervical tumours. Limited information is available about HPV integration in head and neck tumours (HNC). In this study, we have characterised the physical status of HPV in a set of tonsillar tumour samples using different methods—the mapping of E2 integration breakpoint at the mRNA level, the 3’ RACE based Amplification of Papillomavirus Oncogene Transcripts (APOT) assay and Southern blot. Furthermore, the impact of HPV integration on patients' prognosis has been evaluated in a larger set of 186 patients with head and neck cancer. Based on the analysis of E2 mRNA, HPV was integrated in the host genome in 43% of the HPV‐positive samples. Extrachromosomal or mixed form was present in 57%. In fresh frozen samples, the APOT and E2 mapping results were in agreement. The results were confirmed using Southern blotting. Furthermore, the type and exact site of integration were determined. The survival analysis of 186 patients revealed HPV positivity, tumour size and lymph node positivity as factors that influence disease specific survival. However, no statistically significant difference was found in disease specific survival between patients with HPV‐positive integrated vs. extrachromosomal/mixed forms of the virus.